Maurizio M. Federico

Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Towards an Original Anti-ASFV Vaccine: Cellular Immunity Induced by Extracellular Vesicles Engineered with ASFV Proteins.

Towards an Original Anti-ASFV Vaccine: Cellular Immunity Induced by Extracellular Vesicles Engineered with ASFV Proteins.

Journal: Vaccines

Published: May 13, 2026

Potential Impact of SARS-CoV-2 Spike Protein on HIV-1 Reservoir in People Living with HIV.

Potential Impact of SARS-CoV-2 Spike Protein on HIV-1 Reservoir in People Living with HIV.

Journal: Viruses

Published: November 13, 2025

The Potential of Extracellular Vesicle-Mediated Spread of Self-Amplifying RNA and a Way to Mitigate It.

The Potential of Extracellular Vesicle-Mediated Spread of Self-Amplifying RNA and a Way to Mitigate It.

Journal: International journal of molecular sciences

Published: April 28, 2025

The Immunologic Downsides Associated with the Powerful Translation of Current COVID-19 Vaccine mRNA Can Be Overcome by Mucosal Vaccines.

The Immunologic Downsides Associated with the Powerful Translation of Current COVID-19 Vaccine mRNA Can Be Overcome by Mucosal Vaccines.

Journal: Vaccines

Published: October 11, 2024

Extracellular vesicle-based anti-HOXB7 CD8+ T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neu.

Extracellular vesicle-based anti-HOXB7 CD8+ T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neu.

Journal: Cancer gene therapy

Published: May 24, 2024

The Limitations of Current T Cell-Driven Anticancer Immunotherapies Can Be Overcome with an Original Extracellular-Vesicle-Based Vaccine Strategy.

The Limitations of Current T Cell-Driven Anticancer Immunotherapies Can Be Overcome with an Original Extracellular-Vesicle-Based Vaccine Strategy.

Journal: Vaccines

Published: November 14, 2023

SARS-CoV-2-Specific CD8+ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection.

SARS-CoV-2-Specific CD8+ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection.

Journal: Vaccines

Published: July 29, 2023

Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles.

Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles.

Journal: NPJ vaccines

Published: January 26, 2023

How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?

How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?

Journal: International journal of molecular sciences

Published: August 04, 2022

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein.

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein.

Journal: Vaccines

Published: May 24, 2022

Extracellular Vesicles and Their Use as Vehicles of Immunogens.

Extracellular Vesicles and Their Use as Vehicles of Immunogens.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 25, 2022

Biological and Immune Responses to Current Anti-SARS-CoV-2 mRNA Vaccines beyond Anti-Spike Antibody Production.

Biological and Immune Responses to Current Anti-SARS-CoV-2 mRNA Vaccines beyond Anti-Spike Antibody Production.

Journal: Journal of immunology research

Published: April 15, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026